FENBENDAZOLE and CANCER - at least 12 Anti-Cancer mechanisms of action. Not approved by FDA. Cheap. Safe. Kills aggressive cancers. Why no Clinical Trials?
I review 9 research papers proving anti-cancer effects of Fenbendazole.
Benzimidazole drugs (including Fenbendazole) have widely been used as anti-helminth agents in both human and/or livestock since the 1960s
Due to their low cost and high efficacy, benzimidazole anthelmintics have been used throughout the world
Ivermectin is FDA approved.
Fenbendazole is NOT approved for human use by Food and Drug Administration (FDA) and European Medicines Agency (EMA).
A close relative of Fenbendazole called Mebendazole is approved by FDA and has several Clinical Trials for Cancer Treatments in Brain cancer and Colon cancer. It's way more expensive!
Why no Clinical Trials currently for Fenbendazole? It's cheap! No one will get rich off Fenbendazole.
Fenbendazole has at least 12 proven anti-cancer mechanisms in vitro and in vivo:
disrupts microtubule polymerization (major mechanism)
blocks glucose transport and impairs glucose utilization by cancer cells (major)
increases p53 tumor suppressor levels! (major)
inhibits cancer cell viability, migration, invasion
What about COVID-19 mRNA Vaccine Induced Turbo Cancers?
Fenbendazole shows in vitro and/or in vivo activity against these cancers:
breast cancer (including triple negative breast cancer - which is seen in COVID-19 mRNA Vaccinated individuals with Turbo Cancer)
lymphomas (these are the most common COVID-19 mRNA Vaccine Turbo Cancers and there is more evidence for Fenbendazole treating Lymphomas than with Ivermectin)
leukemias (most aggressive COVID-19 mRNA Vaccine Turbo Cancers - patients have no good treatment options)
glioblastomas and gliomas (extremely aggressive COVID-19 mRNA Vaccine Turbo Cancers with poor prognosis - patients have no good treatment options)
lung cancer (NSCLC) (strong signal for COVID-19 mRNA Vaccine Turbo Cancers)
hepatocellular carcinoma (signal for COVID-19 mRNA Vaccine Turbo Cancers and all hepatobiliary cancers including Gallbladder and pancreas)
rhabdomyosarcomas (possible signal for COVID-19 mRNA Vaccine Turbo Cancers, sarcomas in general are on the rise after mRNA vaccination and they are extremely aggressive)
ovarian cancers
Although the anti-parasitic Fenbendazole is not FDA approved for human use, there is extensive evidence of anti-cancer effects in the published literature, both in vitro and in vivo
This is NOT a controversial medication, as it has been made out to be! Don't let the smears mislead you.
This is a serious anti-cancer agent!
Fenbendazole has an excellent safety profile and its close relative, Mebendazole is FDA approved, and it’s undergoing several Clinical Trials for Cancer Treatments in the US right now, including colon cancers and brain cancers.
I believe that it is a reasonable hypothesis that COVID-19 mRNA Vaccine Turbo Cancer patients could benefit significantly from either Mebendazole or Fenbendazole and I would love to see urgent clinical trials with both.
Fenbendazole had Clinical Trials in the past - again, not a controversial medication.
More in the article (including Joe Tippens Cancer Protocol that he used for terminal Small Cell Lung Cancer, other Cancer protocols using Fenbendazole 444mg, etc):
Article Link in photo to avoid shadowban, just re-type URL into your browser
#DiedSuddenly #cdnpoli #ableg